Company / Shares Outstanding
Neurocrine Biosciences Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
99.4M
FY2025
5-year range
93.5M / 99.4M
FY2021-FY2025
Trend
+0.7%
vs FY2024
Sector context
#96 of 212
Health Care
What the data says
At 99400000.00, Neurocrine Biosciences's shares outstanding ranks #117 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 86262594.00 in FY2016 to 99400000.00 in FY2025.
Based on SEC 10-K filings.
99400000.00 in FY2025 with a 5-year CAGR of +1.5%.
Increased from 96500000.00 to 99400000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +1.6%
- 5-Year CAGR
- +1.5%
- 10-Year CAGR
- -
Sector benchmark
#117 of 212 in Health CareTop 55% of 212This company 99.4M Sector average 306.0M
▼
-67.5% below sector average
Key checks
Key Insights
- Neurocrine Biosciences's shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 0.7% year-over-year.
- Ranks #96 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 99.4M | +0.7% |
| FY2024 | 98.7M | +2.3% |
| FY2023 | 96.5M | +1.7% |
| FY2022 | 94.9M | +1.5% |
| FY2021 | 93.5M | +1.3% |
| FY2020 | 92.3M | +1.7% |
| FY2019 | 90.8M | +2.3% |
| FY2018 | 88.8M | +2.2% |
| FY2017 | 86.9M | +0.7% |
| FY2016 | 86.3M | +12.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026